-
941por Papaneophytou, Christos, Nicolaou, Andria, Pieri, Myrtani, Nicolaidou, Vicky, Galatou, Eleftheria, Sarigiannis, Yiannis, Pantelidou, Markella, Panayi, Pavlos, Thoma, Theklios, Stavraki, Antonia, Argyrou, Xenia, Kalogiannis, Tasos, Yiannoukas, Kyriacos, Petrou, Christos C., Felekkis, Kyriacos“…After this study we report that the plasma levels of IgG antibodies against SARS-CoV-2 spike protein were higher in individuals with evidence of prior infection who received at least one dose of either an mRNA-based vaccine (Comirnaty BNT162b2/Pfizer-BioNTech or Spikevax mRNA-1273/Moderna) or an adenoviral-based vaccine (Vaxzervia ChAdOx1 nCoV-19 /Oxford-Astra Zeneca) (n = 39) compared to i) unvaccinated individuals with evidence of prior infection with SARS-CoV-2 (n = 109) and ii) individuals without evidence of prior infection with SARS-CoV-2 who received one or two doses of one of the aforementioned vaccines (n = 342). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
942por Lee, Chiyun, Lin, Junxia, Prokop, Andrzej, Gopalakrishnan, Vancheswaran, Hanna, Richard N., Papa, Eliseo, Freeman, Adrian, Patel, Saleha, Yu, Wen, Huhn, Monika, Sheikh, Abdul-Saboor, Tan, Keith, Sellman, Bret R., Cohen, Taylor, Mangion, Jonathan, Khan, Faisal M., Gusev, Yuriy, Shameer, Khader“…StarGazer displays target prioritization scores for genes associated with 1844 phenotypic traits, and is available via https://github.com/AstraZeneca/StarGazer.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
943“…The purpose of the current study is to compare the severity of COVID-19 pneumonia using CT-SS in COVID-19-positive vaccinated (Covishield/Oxford-AstraZeneca) and non-vaccinated individuals and to compare the final outcome wherever possible. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
944por Choi, Mihyun, Seo, Min-Hwan, Choi, Kwang-Eon, Lee, Sukyeon, Choi, Boyoon, Yun, Cheolmin, Kim, Seong-Woo, Kim, Yong Yeon“…Twelve patients (75%) had been vaccinated with the AstraZeneca (AZD1222) and four (25%) with the Pfizer (BNT162b2) vaccines. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
945por Staniszewska, Anna D., Armenia, Joshua, King, Matthew, Michaloglou, Chrysiis, Reddy, Avinash, Singh, Maneesh, San Martin, Maryann, Prickett, Laura, Wilson, Zena, Proia, Theresa, Russell, Deanna, Thomas, Morgan, Delpuech, Oona, O’Connor, Mark J., Leo, Elisabetta, Angell, Helen, Valge-Archer, ViiaEnlace del recurso
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
946por Stosic, Maja, Milic, Marija, Markovic, Milos, Kelic, Ivana, Bukumiric, Zoran, Veljkovic, Marko, Kisic Tepavcevic, Darija, Saponjic, Vladan, Plavsa, Dragana, Jovanovic, Sofija, Jovanovic, Verica“…The Republic of Serbia applied the booster dose of the following COVID-19 vaccines: BNT162b2 mRNA (Pfizer-BioNTech), Sinopharm BBIBP-CorV (Vero Cell(®)), Gam-COVID-Vac (Sputnik V) and ChAdOk1 nCoV-19 (AstraZeneca). We aimed to examine the immunogenicity and reactogenicity of the booster dose and identify factors related to immune response and adverse events. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
947por Mehta, Pankti, Paul, Aby, Ahmed, Sakir, Cherian, Somy, Panthak, Ameya, Benny, Janet, Shenoy, Padmanabha“…There is paucity of data on extended dosing interval between two doses of AZD1222 (AstraZeneca) in patients with Autoimmune Rheumatic Diseases (AIRD). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
948por Hadi Al Kazzaz, Hassan“…Pfizer was the most preferred by 64 (34.8%), AstraZeneca by 17 (9.2%), and Chinse-Sinovac by only 11 (6%). 20 students (16.4%) believed that with the vaccine they could return to life as it was before the COVID-19 pandemic. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
949“…Over the 10‐year life of the initiative, the industry partners included: AstraZeneca; AbbVie (formerly Abbott); Bristol‐Myers Squibb; Eli Lilly and Company; GlaxoSmithKline; Janssen Pharmaceutical Research & Development, L.L.C.; Pfizer; Sanofi; and Mereo (out licensed assets). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
950por Alahmad, Abdulmohsen M, Kamel, Shady A, Alsulimani, Suhaib T, Alharbi, Mohammad S, Alyazidi, Fawaz R, Allhaybi, Yasser A“…Of those vaccinated, 72.1% had received the Pfizer BioNTech vaccine, and 16.5% had received the Oxford-AstraZeneca vaccine. The Delta variant of SARS-CoV-2 was prevalent in most (87.8%) patients. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
951“…Each vaccine could reduce the HVE-corrected all-cause mortality in the epidemic period (VE(Oxford/AstraZeneca) = 0.592 [0.518–0.655], VE(Janssen) = 0.754 [0.628–0.838], VE(Moderna) = 0.573 [0.526–0.615], VE(Pfizer-BioNTech) = 0.487 [0.461–0.513], VE(Sinopharm) = 0.530 [0.496–0.561], and VE(Sputnik) (V) = 0.557 [0.493–0.614]). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
952“…While vaccination is the single most effective intervention to prevent spread of COVID-19, rare thromboembolic events have been reported following vaccination with COVID-19 vaccines ChAdOx1 nCOV-19 (AstraZeneca) and Ad26.COV2·S (Johnson & Johnson/Janssen). …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
953por Bhat, Ramesh, Kamath, Suvidha D., Sequeira, Nicole, Raina, Sunil, Pai, Ganesh S., Sukumar, Dandakeri, Martis, Jacintha“…The majority had taken the vaccine Covishield (manufactured by AstraZeneca), that is, 85.06% (490/576). Infection post the conference was reported in 0.195% (1/576). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
954por Dawoud, Rand, Haddad, Daniel, Shah, Viraj, Patel, Vraj, Abbas, Gohar, Guduru, Sai, Dakka, Amulya, Kaushik, Vishrut, Cheriyath, Pramil“…The proportion of patients who received other vaccines was as follows: the Pfizer vaccine: 31.25%; Sputnik V: 12.5%; Moderna, AstraZeneca, and Covaxin: 6.25% each. The characteristics of joint-related adverse effects following COVID-19 vaccination were analyzed in this study. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
955“…BACKGROUND: Rare cases of thrombosis and thrombocytopenia (thrombosis with thrombocytopenia syndrome [TTS]) have been associated with 2 coronavirus disease 2019 adenovirus vector vaccines: the ChAdOx1 nCoV-19 Vaxzevria vaccine (Oxford/AstraZeneca) and the JNJ-7836735 Johnson & Johnson vaccine (Janssen). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
956por Öhlund, L., Ott, M., Lundqvist, R., Sandlund, M., Renberg, E. Salander, Werneke, U.“…DISCLOSURE: Michael Ott has been a scientific advisory board member of Astra Zeneca Sweden, Ursula Werneke has received funding for educational activities on behalf of Norrbotten Region (Masterclass Psychiatry Programme 2014–2018 and EAPM 2016, Luleå, Sweden): Astra…”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
957por Wang, Hsi-Hao, Wu, Jia-Ling, Chang, Min-Yu, Wu, Hsin-Mian, Ho, Li-Chun, Chi, Po-Jui, Wu, Ching-Fang, Lee, Wan-Chia, Liou, Hung-Hsiang, Hung, Shih-Yuan, Lee, Yi-Che“…This study observed the antibody response and adverse events of AZD1222 (Oxford/AstraZeneca) vaccination in dialysis patients. A prospective cohort study was conducted in E-Da Healthcare Group hospitals between 1 July and 30 November 2021. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
958“…We report a case of a 50-year-old female who developed subacute thyroiditis 6 days post ChAdOx1 nCoV-19 vaccine (AZD1222 produced by AstraZeneca Vaxzevria). The initial thyrotoxic phase was followed by overt hypothyroidism. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
959por Khurshid, Maman, Ansari, Iflah, Ahmad, Hafsa, Ghaffar, Hafsa, Khurshid, Aiman, Shahid, Abia, Essar, Mohammad Yasir, Ullah, Irfan, Cheema, Huzaifa Ahmad“…Over half (51.72%) of the patients complained of facial paralysis following the Oxford-AstraZeneca vaccination. Out of 51 cases, most (88.24%) occurred after the 1st dose. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
960por Al‐Muqarrab, Fatimah J., Alakloby, Omar M., Al Ameer, Mohammed A., Alhajri, Abdulmohsen M.“…BACKGROUND: In Saudi Arabia, three approved vaccines against severe acute respiratory syndrome coronavirus 2 (AstraZeneca [AZD1222], Pfizer‐BioNTech [BNT162b2] and [Ad26. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto